Literature DB >> 24947413

Colon cancer bears overexpression of OTUB1.

Xin Liu1, Wei-Na Jiang2, Ji-Gang Wang3, Hua Chen4.   

Abstract

OBJECTIVE: OTUB1 is a member of deubiquitinating enzymes; however, its expression and function in colon cancer are still unclear. The present study aimed at investigating the expression of OTUB1 in colon cancer and the relationship between the expression and some clinicopathologic parameters.
METHODS: Immunohistochemistry and quantitative real-time PCR were carried out in selected colon cancer and normal mucosa tissues.
RESULTS: The expression of OTUB1 protein in the colon cancer was significantly higher than normal mucosa, and the OTUB1 mRNA in colon cancer was also 3.15-fold higher than the normal mucosa. The higher expression of OTUB1 in colon cancer was related with tumor size, differentiation and lymph node metastasis.
CONCLUSIONS: OTUB1 may play an important role in colon cancer development and metastasis.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Colon cancer; Immunohistochemistry; OTUB1; Quantitative real-time PCR

Mesh:

Substances:

Year:  2014        PMID: 24947413     DOI: 10.1016/j.prp.2014.05.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  16 in total

Review 1.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

2.  miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1.

Authors:  Long Yuan; Peng Yuan; Huijuan Yuan; Zhenlei Wang; Zengci Run; Guanglong Chen; Peng Zhao; Benling Xu
Journal:  Am J Cancer Res       Date:  2017-01-01       Impact factor: 6.166

3.  OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.

Authors:  Honghong Zhou; Yongshuo Liu; Rui Zhu; Fang Ding; Xiufeng Cao; Dongxin Lin; Zhihua Liu
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

4.  OTUB1 attenuates neuronal apoptosis after intracerebral hemorrhage.

Authors:  Lili Xie; Aihong Li; Jiabing Shen; Maohong Cao; Xiaojin Ning; Debin Yuan; Yuteng Ji; Hongmei Wang; Kaifu Ke
Journal:  Mol Cell Biochem       Date:  2016-09-15       Impact factor: 3.396

5.  OTUB1 promotes tumor invasion and predicts a poor prognosis in gastric adenocarcinoma.

Authors:  Weiwei Weng; Qiongyan Zhang; Midie Xu; Yong Wu; Meng Zhang; Chen Shen; Xiaochen Chen; Yiqin Wang; Weiqi Sheng
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

6.  Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases.

Authors:  Dakshinamurthy Sivakumar; Vikash Kumar; Michael Naumann; Matthias Stein
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

Review 7.  Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases.

Authors:  Chengheng Liao; Qing Zhang
Journal:  Am J Pathol       Date:  2020-04-24       Impact factor: 4.307

8.  OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.

Authors:  Diego Iglesias-Gato; Yin-Choy Chuan; Ning Jiang; Charlotte Svensson; Jing Bao; Indranil Paul; Lars Egevad; Benedikt M Kessler; Pernilla Wikström; Yuanjie Niu; Amilcar Flores-Morales
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

9.  Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.

Authors:  Yi-qin Wang; Qiong-yan Zhang; Wei-wei Weng; Yong Wu; Yu-Si Yang; Chen Shen; Xiao-chen Chen; Lei Wang; Kai-jing Liu; Mi-die Xu; Wei-qi Sheng
Journal:  Int J Biol Sci       Date:  2016-03-03       Impact factor: 6.580

10.  OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.

Authors:  U Karunarathna; M Kongsema; S Zona; C Gong; E Cabrera; A R Gomes; E P S Man; P Khongkow; J W-H Tsang; U-S Khoo; R H Medema; R Freire; E W-F Lam
Journal:  Oncogene       Date:  2015-07-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.